Francisco Partners offloaded approximately $5.48 million of GoodRx Class A shares in late August.
The major shareholder sold over 1.29 million shares on August 26.
These August 26 transactions generated approximately $4.5 million in proceeds.
Weighted average prices for the sales ranged from $3.44 to $3.51 per share.
Filings indicate the sales were not made under a pre-arranged Rule 10b5-1 trading plan.
The consistent divestment by a 10% owner may pressure the stock as the market absorbs the volume.